Multiple health behaviors and serum hepatic enzymes among US adults with obesity

Preventive Medicine

Volumn 53, Issue 4-5, 2011, Pages 278-283

  Tsai, James ^a   Ford, Earl S ^a   Zhao, Guixiang ^a   Croft, Janet B ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Alanine aminotransferase (ALT); Aspartate aminotransferase (AST); Cigarette smoking; Excessive drinking; Gamma glutamyl transferase (GGT); Multiple health behaviors; Obesity; Physical activity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEALTH BEHAVIOR; HUMAN; MALE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEALTH BEHAVIOR; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; NUTRITION SURVEYS; OBESITY; SELF REPORT; UNITED STATES; YOUNG ADULT;

EID: 80955144148     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2011.08.028     Document Type: Article

References (56)

1. American Diabetes Association (ADA) Diagnosis and classification of diabetes mellitus. Diabetes Care 2011, 34:S62-S69.
2. Alatalo P., Koivisto H., Hietala J., Puukka K., Bloigu R., Niemela O. Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index. Am. J. Clin. Nutr. 2008, 88:1097-1103.
3. Alatalo P., Koivisto H., Puukka K., et al. Biomarkers of liver status in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol. 2009, 44:199-203.
4. APHA Alcohol Screening and Brief Intervention: A Guide for Public Health Practitioners 2008, National Highway Traffic Safety Administration, U.S. Department of Transportation. American Public Health Association (APHA) and Education Development Center, Inc., Washington DC.
5. Barros A.J., Hirakata V.N. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med. Res. Methodol. 2003, 3:21.
6. Bluher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr. Opin. Lipidol. 2010, 21:38-43.
7. Bouchard D.R., Langlois M.F., Brochu M., Dionne I.J., Baillargeon J.P. Metabolically healthy obese women and functional capacity. Metab. Syndr. Relat. Disord. 2011, 9:225-229.
8. Bray G.A. Medical consequences of obesity. J. Clin. Endocrinol. Metab. 2004, 89:2583-2589.
9. CDC Recommended community strategies and measurements to prevent obesity in the United States. MMWR 2009, 58:1-26.
10. CDC The Guide to Community Preventive Services 2009, Centers for Disease Control and Prevention, Atlanta, Georgia, Url:. http://www.thecommunityguide.org/pa/index.html.
11. CDC National Health and Nutrition Examination Survey 2010, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, Url:. http://www.cdc.gov/nchs/nhanes.htm.
12. Chang Y., Ryu S., Sung E., Jang Y. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin. Chem. 2007, 53:686-692.
13. Chen P.H., Chen J.D., Lin Y.C. A better parameter in predicting insulin resistance: obesity plus elevated alanine aminotransferase. World J. Gastroenterol. 2009, 15:5598-5603.
14. Conway B., Rene A. Obesity as a disease: no lightweight matter. Obes. Rev. 2004, 5:145-151.
15. DHHS 2008 Physical Activity Guidelines for Americans 2008, US Department of Health and Human Services, Hyattsville, MD, Url:. http://www.health.gov/paguidelines.
16. Ford E.S., Schulze M.B., Bergmann M.M., Thamer C., Joost H.G., Boeing H. Liver enzymes and incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Diabetes Care 2008, 31:1138-1143.
17. Ford E.S., Bergmann M.M., Kroger J., Schienkiewitz A., Weikert C., Boeing H. Healthy living is the best revenge: findings from the European Prospective Investigation Into Cancer and Nutrition-Potsdam study. Arch. Intern. Med. 2009, 169:1355-1362.
18. Ford E.S., Li C., Zhao G., Tsai J. Trends in obesity and abdominal obesity among adults in the United States from 1999-2008. Int. J. Obes. 2010, 35:736-743.
19. Goldstein M., Whitlock E., DePue J. Multiple behavioral risk factor interventions in primary care. Summary of research evidence. Am. J. Prev. Med. 2004, 27:61-79.
20. Guh D., Zhang W., Bansback N., Amarsi Z., Birmingham C.L., Anis A. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009, 9:88.
21. Hammond R.A., Levine R. The economic impact of obesity in the United States. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:285-295.
22. Hart C.L., Morrison D.S., Batty G.D., Mitchell R.J., Davey Smith G. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ 2010, 340:c1240.
23. Johnson S.S., Paiva A.L., Cummins C.O., et al. Transtheoretical model-based multiple behavior intervention for weight management: effectiveness on a population basis. Prev. Med. 2008, 46:238-246.
24. Karelis A.D. Metabolically healthy but obese individuals. Lancet 2008, 372:1281-1283.
25. Khaw K.T., Wareham N., Bingham S., Welch A., Luben R., Day N. Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study. PLoS Med. 2008, 5:e12.
26. Kim H.C., Nam C.M., Jee S.H., Han K.H., Oh D.K., Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 2004, 328:983.
27. Korn E., Graubard B. Analysis of Health Surveys 1999, John Wiley and Sons, Inc., New York.
28. Lee T.H., Kim W.R., Benson J.T., Therneau T.M., Melton L.J. Serum aminotransferase activity and mortality risk in a United States community. Hepatology 2008, 47:880-887.
29. Mason J., Starke R., Van Kirk J. Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Prev. Cardiol. 2010, 13:36-41.
30. NACB Laboratory Medicine Practice Guidelines: Laboratory Guidelines for Screening, Diagnosis and Monitoring of Hepatic Injury 2000, The National Academy of Clinical Biochemistry (NACB), Washington, DC.
31. NIAAA National Institute on Alcohol Abuse and Alcoholism. Helping Patients Who Drink Too Much: A Clinician's Guide 2005, NIH Pub No. 05-3769. Bethesda, MD.
32. Nyblom H., Berggren U., Balldin J., Olsson R. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol Alcohol. 2004, 39:336-339.
33. Ogden C., Yanovski S., Carroll M., Flegal K. The epidemiology of obesity. Gastroenterology 2007, 132:2087-2102.
34. Prochaska J.J., Velicer W.F., Prochaska J.O., Delucchi K., Hall S.M. Comparing intervention outcomes in smokers treated for single versus multiple behavioral risks. Health Psychol. 2006, 25:380-388.
35. Prochaska J.J., Spring B., Nigg C.R. Multiple health behavior change research: an introduction and overview. Prev. Med. 2008, 46:181-188.
36. Puukka K., Hietala J., Koivisto H., Anttila P., Bloigu R., Niemela O. Additive effects of moderate drinking and obesity on serum gamma-glutamyl transferase activity. Am. J. Clin. Nutr. 2006, 83:1351-1354. quiz 1448-1359.
37. Ruhl C.E., Everhart J.E. Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Clin. Gastroenterol. Hepatol. 2005, 3:1260-1268.
38. Ruhl C.E., Everhart J.E. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology 2009, 136:477-485.
39. Sato K.K., Hayashi T., Nakamura Y., et al. Liver enzymes compared with alcohol consumption in predicting the risk of type 2 diabetes: the Kansai Healthcare study. Diabetes Care 2008, 31:1230-1236.
40. Smith G., Bracha Y., Svendsen K., Neaton J., Haffner S., Kuller L. Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial. Ann. Intern. Med. 2005, 142:313-322.
41. St George A., Bauman A., Johnston A., Farrell G., Chey T., George J. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors. J. Gastroenterol. Hepatol. 2009, 24:399-407.
42. St George A., Bauman A., Johnston A., Farrell G., Chey T., George J. Independent effects of physical activity in patients with nonalcoholic fatty liver disease. Hepatology 2009, 50:68-76.
43. Stockwell T., Donath S., Cooper-Stanbury M., Chikritzhs T., Catalano P., Mateo C. Under-reporting of alcohol consumption in household surveys: a comparison of quantity-frequency, graduated-frequency and recent recall. Addiction 2004, 99:1024-1033.
44. Stranges S., Dorn J.M., Muti P., et al. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology 2004, 39:754-763.
45. Stranges S., Freudenheim J.L., Muti P., et al. Differential effects of alcohol drinking pattern on liver enzymes in men and women. Alcohol. Clin. Exp. Res. 2004, 28:949-956.
46. Sullivan P.W., Ghushchyan V., Ben-Joseph R.H. The effect of obesity and cardiometabolic risk factors on expenditures and productivity in the United States. Obesity (Silver Spring) 2008, 16:2155-2162.
47. Targher G. Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer - a narrative review. Clin. Chem. Lab. Med. 2010, 48:147-157.
48. Tsai J., Ford E.S., Li C., Zhao G., Balluz L.S. Physical activity and optimal self-rated health of adults with and without diabetes. BMC Public Health 2010, 10:365.
49. Tsai J., Ford E.S., Li C., Zhao G., Pearson W.S., Balluz L.S. Multiple healthy behaviors and optimal self-rated health: findings from the 2007 Behavioral Risk Factor Surveillance System Survey. Prev. Med. 2010, 51:268-274.
50. Tsai J., Ford E.S., Zhao G., Li C., Greenlund K.J., Croft J.B. Co-occurrence of obesity and patterns of alcohol use associated with elevated serum hepatic enzymes in U.S. adults. J. Behav. Med. 2011, 10.1007/s10865-011-9353-5.
51. USPSTF Screening for obesity in adults: recommendations and rationale. Am. J. Nurs. 2004, 104(94-95):97-98. 100, passim.
52. USPSTF US Preventive Services Task Force. Counseling and Interventions to Prevent Tobacco Use and Tobacco-Caused Disease in Adults and Pregnant Women 2009, URL:. http://www.uspreventiveservicestaskforce.org/uspstf/uspstbac2.htm.
53. Vanbuskirk K., Potenza M. The treatment of obesity and its co-occurrence with substance use disorders. J Addict. Med. 2010, 4:1-10.
54. Vozarova B., Stefan N., Lindsay R.S., et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002, 51:1889-1895.
55. Wannamethee S.G., Shaper A.G. Cigarette smoking and serum liver enzymes: the role of alcohol and inflammation. Ann. Clin. Biochem. 2010, 47:321-326.
56. Zhao G., Ford E.S., Li C., et al. Serious psychological distress and its associations with body mass index: findings from the 2007 Behavioral Risk Factor Surveillance System. Int. J. Public Health 2009, 54(Suppl. 1):30-36.